This study will evaluate the safety and effectiveness of an investigational drug for multiple types of advanced cancer that haven't responded to treatment and have spread to other parts of the body (metastatic).
Seeking men whose prostate cancer has progressed despite previous treatment with hormone therapy and chemotherapy (also known as castration resistant prostate cancer) for a study comparing treatment using an investigational drug combination to treatment using one of two different usual treatments for metastatic prostate cancer.
Non-squamous non-small cell lung cancer patients whose cancer has been tested to be PD-L1 positive (a kind of tumor marker) sought for study comparing two usual approaches to treatment.